Status:
UNKNOWN
Biomarker Analysis of Gastrointestinal Cancer
Lead Sponsor:
Samsung Medical Center
Conditions:
Gastrointestinal Cancer
Eligibility:
All Genders
18+ years
Brief Summary
BIOMARKER ANALYSES 1. FNA Sample: From each enrolled patient who meets the inclusion criteria, FNA sample will only be taken . FNA will be carried out only in patients with feasible biopsy or...
Detailed Description
Recently, a great leap has been accomplished in discovering somatic mutations in human cancer genomes. With the advent of molecularly targeted therapy, somatic mutations have attracted more attention ...
Eligibility Criteria
Inclusion
- Inclusion Criteria:
- Patients with histologically confirmed gastrointestinal cancer.
- Patients should sign a written informed consent .
Exclusion
Key Trial Info
Start Date :
September 1 2011
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
Estimated Enrollment :
500 Patients enrolled
Trial Details
Trial ID
NCT01484444
Start Date
September 1 2011
Last Update
December 6 2011
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Samsung medical Center
Seoul, South Korea